A phase II study of a doublet metronomic chemotherapy regimen consisting of oral vinorelbine and capecitabine in Chinese women with HER2-negative metastatic breast cancer.

Yue Chai,Jiaxuan Liu,Mingxia Jiang,Maiyue He,Zijing Wang,Fei Ma,Jiayu Wang,Peng Yuan,Yang Luo,Binghe Xu,Qiao Li

Thoracic cancer（2023）

引用 0|浏览3

暂无评分

摘要

The dual oral mNC regimen showed very good safety features and improved compliance without loss of efficacy in both first- and second-line treatments. The regimen also reached an excellent ORR in the mTNBC subgroup.

查看译文

关键词

breast cancer, capecitabine, metastasis, metronomic chemotherapy, vinorelbine

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要